An Overview on Potential of Piperine as a Bioavailability Enhancer

Authors

  • Abhishek Jain
  • Anjali Desai
  • Prakash Jain

Abstract

Oral absorption of drug is significant issue particularly when the medication is ineffectively bioavailable, given for extensive stretches and costly. Bioenhancers can be characterized as substance elements, which when blended in with drugs advance and expand their bioavailability without indicating any synergistic impact with the medication. The elements like poisonousness, cost, helpless bioavailability and long haul organization of medications offer ascent to the need of bioenhancers which help conquer the vast majority of these issues. Flute player species produce a sharp alkaloid named Piperine or 1-peperoyl piperidine. Piperine expands penetrability at the site of ingestion by adjusting lipid climate and film elements. Piperine has an atomic structure that is appropriate for chemical hindrance. It enlarges the bioavailability of a few medications like carbamazepine, curcumin, ciprofloxacin, ampicillin, metronidazole, oxytetracycline and numerous others by restraining different processing catalysts. Consequently piperine, being a solid inhibitor of medication digestion is a ground-breaking enhancer of retention. The accompanying audit investigates the system, digestion restraint, impact of primary changes on action, and medications bioenhanced by piperine. It gives a knowledge on the utilization of piperine as a successful bioenhancer and the predominance of a bioenhanced drug definition over the one without a bioenhancer Bioenhancers or bioavailability enhancers are generally the plant-based atoms which advance the natural movement or bioavailability or the take-up of medications in blend treatment. This survey article closes the bioavailability improving property of piperine.


Keywords: Bioenhancers, Piperine, Oral absorption, Alkaloid.

 

Cite this Article

Abhishek Jain, Anjali Desai, Prakash Jain. An Overview on Potential of Piperine as a Bioavailability Enhancer. Research & Reviews: A Journal of Drug Formulation, Development and Production. 2020; 7(3): 41–47p.

Downloads

Published

2021-01-16

Issue

Vol. 7 No. 3 (2020)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.